» Articles » PMID: 10218775

Hippocampal Synaptic Plasticity in Streptozotocin-diabetic Rats: Impairment of Long-term Potentiation and Facilitation of Long-term Depression

Overview
Journal Neuroscience
Specialty Neurology
Date 1999 Apr 28
PMID 10218775
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Streptozotocin-diabetic rats, an animal model for diabetes mellitus, show learning deficits and impaired long-term potentiation in the CA1-field of the hippocampus. The present study aimed to further characterize the effects of streptozotocin-diabetes on N-methyl-D-aspartate receptor-dependent long-term potentiation in the CA1-field, to extend these findings to N-methyl-D-aspartate receptor-dependent and independent long-term potentiation in other regions of the hippocampus and to examine effects on long-term depression. First, the effect of diabetes duration on long-term potentiation in the CA1-field was determined. A progressive deficit was observed after a diabetes duration of six to eight weeks, which reached a maximum after 12 weeks of diabetes and remained stable thereafter. Next, long-term potentiation was examined in the dentate gyrus and in the CA3-field after 12 weeks of diabetes. Both were found to be impaired compared to controls. Finally, long-term depression was examined in the CA1-field of the hippocampus after 12 weeks of diabetes and found to be enhanced in slices from diabetic rats compared to controls. Changes in synaptic plasticity were observed in hippocampal slices from streptozotocin-diabetic rats. Expression of N-methyl-D-aspartate receptor-dependent long-term potentiation was impaired in the CA1-field and dentate gyrus and expression of N-methyl-D-aspartate receptor-independent long-term potentiation was impaired in the CA3-field. In contrast, expression of long-term depression was facilitated in CA1. It is suggested that this combination of changes in plasticity may reflect alterations in intracellular signalling pathways.

Citing Articles

Cognitive Impairment and Synaptic Dysfunction in Cardiovascular Disorders: The New Frontiers of the Heart-Brain Axis.

Soda T, Pasqua T, De Sarro G, Moccia F Biomedicines. 2024; 12(10).

PMID: 39457698 PMC: 11504205. DOI: 10.3390/biomedicines12102387.


Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway.

Meng X, Li D, Kan R, Xiang Y, Pan L, Guo Y J Neuroinflammation. 2024; 21(1):192.

PMID: 39095838 PMC: 11297729. DOI: 10.1186/s12974-024-03183-8.


Longitudinal study on hippocampal subfields and glucose metabolism in early psychosis.

Armio R, Laurikainen H, Ilonen T, Walta M, Sormunen E, Tolvanen A Schizophrenia (Heidelb). 2024; 10(1):66.

PMID: 39085221 PMC: 11291638. DOI: 10.1038/s41537-024-00475-z.


Differences in action potential propagation speed and axon initial segment plasticity between neurons from Sprague-Dawley rats and C57BL/6 mice.

Chen Z, Peng L, Zhao M, Li Y, Takahiko M, Tao L Zool Res. 2022; 43(4):615-633.

PMID: 35758537 PMC: 9336440. DOI: 10.24272/j.issn.2095-8137.2022.121.


Ser/Thr phosphatases: One of the key regulators of insulin signaling.

Yadav Y, Dey C Rev Endocr Metab Disord. 2022; 23(5):905-917.

PMID: 35697962 DOI: 10.1007/s11154-022-09727-8.